Extended vs. No Pelvic Lymph Node Dissection During Radical Prostatectomy. DISSECTION 2.0.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The aim of the DISSECTION 2.0 study is to determine whether extended pelvic lymph node dissection (ePLND) provides a therapeutic benefit for high-risk prostate cancer patients by improving cancer staging and potentially removing micrometastatic disease, ultimately improving their outcomes.
Epistemonikos ID: c9f09c3ef869fa83ff20e5e45a741c063d19509a
First added on: Feb 01, 2025